Philip Mease, MD
Philip J Mease, MD, is clinical professor of medicine at the University of Washington School of Medicine, and is director of the rheumatology clinical research division at the Swedish Medical Center, in Seattle, Washington. Dr Mease received his undergraduate and medical degrees from Stanford University, California. He completed his residency in internal medicine and his fellowship in rheumatology at the University of Washington.
Dr Mease is a leading researcher and educator on disease state and treatment of rheumatic disorders. His research focuses on emerging therapeutics and outcome measures for clinical trials. He has served as principal or co-principal investigator on numerous clinical trials in RA, PsA, and AS and has authored over 300 articles, numerous abstracts, and book chapters on these and related subjects. He serves on the review boards for The Journal of Rheumatology, Annals of the Rheumatic Diseases, Arthritis & Rheumatism, Arthritis Care & Research, Seminars in Arthritis and Rheumatism, and other leading publications.
Dr Mease is past-President and founding organizer of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), a member of the Assessment of SpondyloArthritis international Society (ASAS) and the Spondyloarthritis Research and Treatment Network (SPARTAN). He is co-chair of the PsA task force of the National Psoriasis Foundation. Dr Mease has been active in the Outcome Measures in Rheumatology Clinical Trials (OMERACT) research organization as co-chair of the PsA and chronic pain working groups. He conducts disease state research in registries such as the Consortium of Rheumatology Researchers of North America (CORRONA) for which he is Director of the Spondyloarthritis and Psoriatic Arthritis arm of the registry. Dr Mease is a recipient of the American College of Rheumatology’s Medical Communicator Award.
Consultancy – AbbVie, Amgen, BMS, Corrona, Crescendo, Galapagos, Janssen, Eli Lilly, Merck, Novartis, Pfizer, UCB, Sun Pharmaceuticals; Speaker bureau – AbbVie, Amgen, BMS, Crescendo, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, UCB; Research grant – AbbVie, Amgen, BMS, Janssen, Eli Lilly, Merck, Novartis, Pfizer, UCB